Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2013-003477-10 | EudraCT Number |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Institut National de la Santé Et de la Recherche Médicale, France | OTHER_GOV |
Not provided
Not provided
Not provided
Not provided
Measured plasmatic concentration of pregnenolone and endocannabinoid in fasting conditions and over a meal in obese and normal-weight men subjects, to research a dysfunction in the negative feed-back between pregnenolone and CB1 ligand in obese subjects. This dysfunction could participate to the hyperactivity of endocannabinoid system saw in obesity.
Endocannabinoid system is an orexigenic key system, controlling the energy balance. It is composed of receptors (ex: CB1), of endogenous ligands, the endocannabinoids (ex: anandamide and 2- arachidonoylglycerol) and of enzymes implied in the synthesis and the degradation of the endocannabinoids. Researches resulting from our group highlighted anomalies of the plasmatic concentrations of endocannabinoid, in obese subject compared to normal-weight subject. Those being higher in obese subject with a flatness of post prandial reduction of AEA, so maintenance of elevated levels which can facilitate the food catch and create a metabolic vicious circle. In addition, prestigious research resulting from our collaborators highlighted in the animal that exposure to tetrahydrocannabinol (THC, ligand exogenic of CB1) induced the synthesis of pregnenolone (neurosteroid) which, by an autocrine effect on the CB1, inhibited the effects of the THC. In particular one of the principal behavioural effects: the food intake.
We want to measure pregnenolone and endocannabinoid concentrations in men blood samples, to observe if this association exists in fasting conditions and over a meal in normal-weight and obese subjects. Obese subjects will be recruited during an hospitalization, while normal subject will be recruited by a poster at Bordeaux university and Haut-Leveque hospital. They will be included at Haut-Leveque hospital during morning at hospital.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Obese men | Experimental | Measured plasmatic concentration of pregnenolone and endocannabinoid in fasting conditions and over a meal in obese men. |
|
| Normal-weight men | Active Comparator | Measured plasmatic concentration of pregnenolone and endocannabinoid in fasting conditions and over a meal in normal-weight men. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Obese men | Other | Biological measures before, just before, and after lunch, in obese men |
| |
| Measure | Description | Time Frame |
|---|---|---|
| Comparison of pregnenolon plasmatic concentration in both groups. | Pregnenolon plasmatic concentration will be measured at several points. | Change from 1 hour before lunch to 1 hour after lunch at inclusion day |
| Measure | Description | Time Frame |
|---|---|---|
| Comparison of neurosteroid plasma concentrations and endocannabinoid plasma concentrations | Neurosteroid and endocannabinoid plasma concentrations will be measured at several points. | Change from 1 hour before lunch to 1 hour after lunch at inclusion day |
| Comparison of endocannabinoid plasma concentration and pregnenolone plasma concentration |
Not provided
Inclusion Criteria:
Obese subjects:
Normal-weight subjects:
Exclusion Criteria:
For all subjects:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Lhomme Edouard, Dr | USMR | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hôpital Haut-Lévêque | Pessac | 33600 | France |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D009765 | Obesity |
| ID | Term |
|---|---|
| D050177 | Overweight |
| D044343 | Overnutrition |
| D009748 | Nutrition Disorders |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
Obese men versus normal-weight men
Not provided
Not provided
Not provided
Not provided
| Normal-weight men |
| Other |
Biological measures before, just before, and after lunch, in normal-weight men. |
|
Endocannabinoid and pregnenolone concentrations will be measured at several points. |
| Change from 1 hour before lunch to 1 hour after lunch at inclusion day |
| D001835 |
| Body Weight |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |